Eisai Co., Ltd.

Overview

Eisai Co., Ltd. is a leading global pharmaceutical company headquartered in Japan. It is focused on the research, development, and distribution of innovative treatments for various therapeutic areas. The company is well-known for its work in neurology and oncology.

Core services & business areas

Pharmaceutical ProductionQuality ControlPackagingRegulatory Affairs

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Eisai Co., Ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Eisai Co., Ltd. holds 1 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • MOH040Active2019-03-27
  • INTERLEUKIN-2 DIPHTHERIA TOXIN FUSION PROTEIN (DAB 389 IL-2)Inactive1992-08-14
  • EPERISONEInactive1989-04-04
  • MENFEGOLInactive1985-06-28
  • BENTIROMIDEInactive1984-05-31

FDA compliance signals

26 FDA enforcement records linked to this company.

  • 4832023-10-27

    Storage under appropriate conditions

  • 4832023-10-27

    Procedures not in writing, fully followed

  • 4832018-12-21

    Training , Education , Experience overall

  • 4832018-12-21

    Written procedures fail to include

  • 4832018-12-21

    Calibration/Inspection/Checking not done

  • 4832018-12-21

    Records not made readily available to FDA

  • 4832018-12-21

    Following/documenting laboratory controls

  • 4832018-12-21

    Cleaning / Sanitizing / Maintenance

  • 4832018-12-21

    Establishment of time limitations

  • 4832016-07-22

    Complete test data included in records

  • 4832016-07-22

    Computer control of master formula records

  • 4832016-07-22

    Following/documenting laboratory controls

  • 4832016-07-22

    Rejected in-process materials not quarantined

  • 4832016-07-22

    Extent of discrepancy, failure investigations

  • 4832015-12-10

    Written warehousing procedures established/followed

Verified Supplier Partner

Is this Eisai Co., Ltd.? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.